Legal Disputes in Cardiology
In upstate New York, patients risk losing care as Ellis Medicine and St. Peter’s Health Partners engage in a legal battle over the non-compete agreements of 27 cardiologists. This situation could significantly impact patient access to cardiovascular care.
Updated Guidelines for Noncardiac Surgery
American guidelines have been updated regarding perioperative cardiovascular management for noncardiac surgery, with a strong recommendation to discontinue SGLT-2 inhibitors 3 to 4 days prior to surgery, reflecting the latest evidence-based practices.
Stroke Treatment Advances
For stroke patients, the benefit of intra-arterial tenecteplase following successful endovascular thrombectomy has been sustained out to 12 months, demonstrating the long-term efficacy of this treatment approach according to a secondary analysis of ANGEL-TNK.
Understanding Functional Decline
Evidence indicates that functional decline can be recognized as early as a decade before a cardiovascular disease (CVD) event. This finding emphasizes the importance of early identification and monitoring of higher-risk individuals, providing a prolonged window for preventive interventions.
Investigational Treatments
A recent phase II trial has shown promising safety and efficacy data for investigational tipelukast as a treatment for hypertriglyceridemia and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes.
Microbiome and Cardiometabolic Health
Microbiome-targeted interventions have shown modest associations with improved cardiometabolic markers in childhood, according to a meta-analysis published in the European Journal of Preventive Cardiology.
Blood Pressure Management in Critically Ill Children
For hypotensive critically ill children, the adoption of a permissive mean arterial pressure target did not improve outcomes, highlighting the need for further research in optimizing blood pressure management in this vulnerable population.
Advances in Valve Interventions
Transcatheter tricuspid valve interventions have increasingly become part of real-world practice, demonstrating acceptable outcomes in treated patients, similar to those in pivotal trial populations.
Stroke Risk and GLP-1 Drugs
Recent findings from a Swedish nationwide study indicate that GLP-1 drugs are associated with a reduced stroke risk in individuals with type 2 diabetes, while SGLT-2 inhibitors and DPP-4 inhibitors showed neutral effects.
AI and ECG Monitoring
Tempus AI has received FDA clearance for its ECG-MR artificial intelligence-powered software, designed to identify signs of mitral regurgitation through standard 12-lead ECGs, signaling a step forward in cardiac diagnostics.
Need for Heart Failure Clinics
There is a call for more heart failure clinics in the South and Appalachia, according to a report from the Heart Failure Society of America, to better manage these conditions across diverse populations.
Transcriptomic Biomarkers
A recent study validated HEARTBiT as a transcriptomic biomarker for detecting moderate-to-severe acute cellular rejection after heart transplantation, contributing to the advancement of post-transplant monitoring.
Drones in Cardiac Emergencies
Innovative use of drones has been shown to provide faster access to automated external defibrillators for individuals undergoing out-of-hospital cardiac arrest, particularly in regions with high road traffic, according to research presented at the European Emergency Medicine Congress.
Disclaimer: This information is intended for educational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Fuente: https://www.medpagetoday.com/cardiology/generalcardiology/123185
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
